Evidence map›Paper›PMID 38872732›Full record

ArticleInternational journal of cardiology. Cardiovascular risk and prevention2024

Takotsubo syndrome as an acute cardiac complication following combined chemotherapy.

H A Nati-Castillo, David Aristizabal-Colorado, Carolina López Ordoñez, Diego Egas Proaño, Esteban Ortiz-Prado, Juan S Izquierdo-Condoy

Abstract readCase Reports
In one paragraph

Article in International journal of cardiology. Cardiovascular risk and prevention, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

H A Nati-CastilloGrupo Interinstitucional Medicina Interna (GIMI 1), Universidad Libre, 760042, Cali, Colombia.
David Aristizabal-ColoradoGrupo Interinstitucional Medicina Interna (GIMI 1), Universidad Libre, 760042, Cali, Colombia.
Carolina López OrdoñezHematoncólogos S.A, 760042, City, Colombia.
Diego Egas ProañoImpulso Especialistas en Enfermedades Cardíacas, Hospital Metropolitano de Quito, 170519, Quito, Ecuador.
Esteban Ortiz-PradoOne Health Research Group, Universidad de las Américas, 170137, Quito, Ecuador.
Juan S Izquierdo-CondoyOne Health Research Group, Universidad de las Américas, 170137, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute cardiac complications post-chemotherapy is rare. Stress cardiomyopathy, one of these complications, should be considered in differential diagnoses as its symptoms closely resemble those of acute myocardial infarction and can lead to mortality. Objective: The objective of this paper is to describe Takotsubo syndrome (TTS) as an acute complication following combined chemotherapy in a patient with significant thromboembolic burden and metastatic cervical cancer. Case: A 61-year-old female patient with a diagnosis of metastatic cervical cancer experienced acute chest pain. Elevated troponin levels and abnormalities in the electrocardiogram initially suggested an acute myocardial infarction, occurring after a chemotherapy session involving Carboplatin and Paclitaxel infusion. Although initial treatment targeted myocardial infarction, further diagnostic evaluations including coronary angiography and cardiac magnetic resonance imaging revealed no coronary artery disease but identified features consistent with stress cardiomyopathy, indicative of Takotsubo syndrome (TTS). This diagnosis led to an improvement in symptoms and a resolution of the acute changes observed. Conclusion: Stress cardiomyopathy, particularly TTS, is being increasingly recognized as an acute complication associated with combined chemotherapy regimens. The potential cardiotoxic effects of these chemotherapy agents demand careful monitoring and evaluation in patients undergoing oncological treatment, underscoring the importance of integrating cardioprotective strategies into the management of these patients.

Indexed as

CarboplatinCombined chemotherapyPaclitaxelTakotsubo cardiomyopathy

Identifiers

PMID38872732
PMCPMC11170171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.